Akèy › Kansè Metastatik › Vermont
Etid klinik pou Kansè Metastatik nan Vermont
4 etid pou Kansè Metastatik ap chèche patisipan nan sit nan Vermont.
Vil nan Vermont
Tèks ofisyèl etid la (Anglè)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- The University of Vermont Medical Center Inc., Burlington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- The University of Vermont Medical Center Inc., Burlington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Vermont Medical Center, Burlington
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
- University of Vermont Medical Center, Burlington
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT06778408Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.